Recently, Ningbo Medicalsystem Biotechnology Co., Ltd.’s wholly owned subsidiary - NINGBO ALABAMA,LLC acquiring U.S. Atherotech Inc who is in the bankruptcy. Under the agreement, NINGBO ALABAMA,LLC will have Atherotech’s productive assets and assumed some contracts, but not assumed their creditor's rights and debts.

The third-party medical laboratory services are rising from U.S., after years of development has been basically mature. Because the third-party medical laboratory can concentrate specimens to test. It will greatly reduce the cost, improve the diagnostic efficiency and quality and reduce the incidence of diagnostic errors. It’s one of the important direction of the current developed countries for the development of medical test service industry. According to the estimate, American medical test market in 2013 has reached $55 billion, the independent medical laboratory accounted for about 35% of the market.

Now, Ningbo Medicalsystem is committed to creating the chaining regional medical test center, give full play to the company’s competitive advantage. After this acquisition, on the one hand, it will help the company to develop the medical laboratory services market in the United States, drive sales of the company's products in the international market and set up the international brand image; on the other hand, it will also help the company to import mature markets business philosophy and the international advanced technology of America, realize company’s rapid upgrade of products and technology in the medical test field and gather experience for the company’s development. Especially in the diagnostic of cardiovascular disease, Atherotech have accumulated many years rich experience.